Indolent B-Cell Non-Hodgkin Lymphoma

Also known as: Indolent B-cell NHL / Indolent B-cell non-Hodgkin Lymphoma (NHL) / Indolent B-cell Non-Hodgkin's Lymphoma / Indolent B cell non-hodgkin lymphoma / Indolent B-Cell Non-Hodgkin's Lymphomas

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00928Azacitidine1Active Not Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB01073Fludarabine1Recruiting1
DB00480Lenalidomide1Active Not Recruiting1
DB16582Lisocabtagene maraleucel1Recruiting1
DB08935Obinutuzumab1Active Not Recruiting1
DB00073Rituximab1Completed1
DB17429BI-12061 / 2Recruiting1
DB17573Evorpacept1 / 2Recruiting1
DB00480Lenalidomide1 / 2Recruiting1
DB00073Rituximab1 / 2Recruiting2
DB06769Bendamustine2Completed1
DB15434Mosunetuzumab2Recruiting1
DB00075Muromonab2Recruiting1
DB08935Obinutuzumab2Recruiting1
DB09037Pembrolizumab2Active Not Recruiting1
DB12240Polatuzumab vedotin2Recruiting1
DB18245Zandelisib2Active Not Recruiting1
DB06769Bendamustine3Terminated1